Selected Tag: Cipla
Selected Tag: Cipla

Most Indian Pharma Exports May Escape US Tariff, But Uncertainty Clouds Branded Generics 

US 100% tariff plan sparks confusion: if branded generics are treated as patented drugs, India is safe; if as branded imports, then some pharma exports face trouble.

Ajay Srivastava

September 26, 2025 at 7:56 AM IST

Article related image

Istock.com/moussa81

US FDA Issues OAI Status For Cipla’s Pithampur Plant

BasisPoint Insight

August 6, 2025 at 6:00 AM IST

Cipla April-June Profit Rises 10%, Revenue Growth At 21-Quarter Low

BasisPoint Insight

July 28, 2025 at 6:26 AM IST

Cipla To Buy 20% Stake In Medical Device Firm iCaltech For ₹50 Million

BasisPoint Insight

July 24, 2025 at 8:16 AM IST

Cipla Gets One Form 483 Observation For Bengaluru Unit

BasisPoint Insight

June 2, 2025 at 12:09 PM IST

Cipla To Pick Up 26% Stake In Solar SPV For ₹14.6 Million

BasisPoint Insight

May 21, 2025 at 9:58 AM IST

FDA Tags Cipla Arm Sitec Labs’ Navi Mumbai Unit As ‘Voluntary Action Indicated’

BasisPoint Insight

May 19, 2025 at 10:24 AM IST

Trump's "Most Favored Nation" Plan Exposes Indian Big Pharma's Concentration Risk

New executive order targeting drug prices reveals dangerous US dependency and accelerates the need for market diversification and higher-value products.

Dev Chandrasekhar

May 13, 2025 at 8:26 AM IST

Article related image

Cipla’s Goa Unit Gets ‘Voluntary Action Indicated’ From USFDA

BasisPoint Insight

April 22, 2025 at 8:32 AM IST

The Bureau

Mission Pulses: Does It Pack The Protein Punch India Needs?
Jallikattu: Tamil Nadu’s Ancient Bull-Taming Tradition
Image